-
Panelists to discuss continuous glucose monitoring and its role in type 2 diabetes
CGM technology has the potential for use as a preventative tool in diabetes and obesity, and researchers continue to learn more about the effects of CGM use in people living with diabetes who are treated with insulin and those who are not. Three experts, including Ronnie Aronson, MD, will discuss emerging evidence.
-
Researchers to review health data and rural populations
For many years, rural residents in the United States were healthier as a population than their urban counterparts. In the 1980s, that began to change. Four researchers, including Vasan Ramachandran, MD, DM, FACC, FAHA, will discuss this trend in the context of diabetes diagnosis and care.
-
Professional development session to offer tips to secure funding for innovative ideas
Taking an innovative idea for diabetes care from the bench to the bedside requires funding. Presenters including Kathryn Zavala, PhD, COO and BioTools Innovator Managing Director, MedTech Innovator, will discuss what investors look for in a pitch.
-
Session will review benefits of behavioral diabetes management
Some of the diabetes management tools with the greatest efficacy are those that patients can use by themselves. Experts including Sarah S. Jaser, PhD, will discuss the impact tracking blood glucose levels, sleep quality, diet choices, and other behaviors can have in disease management while paying tribute to behavioral diabetes pioneer Mark Peyrot, PhD.
-
Experts to delve into the nuances of diet makeup in diabetes care
Proper nutrition can help regulate diabetes. Christopher Gardner, PhD, will discuss the advantages of consuming a plant-based, whole-food diet, along with the health and global benefits of switching from animal protein to plant-based protein. Other presenters will discuss portion size and calorie density, and how processed foods impact energy balance.
-
Presenters will define diabetes endotypes in pursuit of precision medicine
The ADA’s Precision Medicine in Diabetes Initiative aims to tap into the potential of individualized medicine to improve the lives of people with diabetes. Genetic testing is one component of this strategy to better understand the disease and refine diagnostics. Rinki Murphy, MBChB, FRACP, PhD, and other experts will discuss why endotypes matter in achieving…
-
Symposium to help providers navigate diabetes foot care
Managing foot care is a challenge people living with diabetes face on a daily basis. David G. Armstrong, DPM, MD, PhD, and other panelists will present approaches providers can implement to help their patients living with diabetes get ahead of foot injuries and improve foot health.
-
More opportunities for attendee engagement and interactivity at the 83rd Scientific Sessions
Attendees in San Diego will experience new program features, educational offerings, and networking opportunities—all intended to enhance the overall Scientific Sessions experience, said Marlon Pragnell, PhD, ADA Vice President of Research & Science. More debates, audience polling, and extended time for questions are among the additions.
-
Scientific Sessions features four days of cutting-edge basic, translational, and clinical science
Scientific Sessions Meeting Planning Committee Chair Alice Y.Y. Cheng, MD, FRCPC, previews the program, featuring more than 190 sessions and 2,000 original research presentations on the latest clinical trial findings, highly anticipated study results, current hot topics, and emerging trends in diabetes research, prevention, and care.
-
SURMOUNT 2 offers new data on tirzepatide use for obesity and type 2 diabetes
Carrying extra weight exacerbates diabetes and can lead to a variety of metabolic and biomechanical complications. In SURMOUNT 2, a GLP-1/GIP dual receptor agonist led to weight loss in patients with both obesity and type 2 diabetes to an extent previously unseen. Investigators including W. Timothy Garvey, MD, will present trial results at the Scientific…